Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept

Dermatologic Therapy

Volumn 27, Issue 4, 2014, Pages 211-214

  Tichy, Martin ^a   Hercogova, Jana ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

Crohn's disease; paradoxical drug reaction (etanercept); psoriasis

Indexed keywords

ADALIMUMAB; CYTOKINE; ETANERCEPT; FOLIC ACID; INFLIXIMAB; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ABDOMINAL PAIN; ADULT; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; CHRONIC DISEASE; CROHN DISEASE; CYTOKINE RELEASE; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG WITHDRAWAL; FEMALE; GENETIC PREDISPOSITION; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LIVER TOXICITY; LOW DRUG DOSE; PARADOXICAL DRUG REACTION; PSORIASIS; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RELAPSE; REMISSION; TREATMENT OUTCOME; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; CROHN DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904901667     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12119     Document Type: Article

References (15)

1. Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G,. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exantemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol 2008: 9 (1): 1-14.
2. Collamer AN, Guerrero KT, Henning JS, Battafarano DF,. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum 2008: 59 (7): 996-1001.
3. Ko JM, Gottlieb AB, Kerbleski JF,. Induction and exacerbation of psoriasis with TNF alpha-blockage therapy: a review and analysis of 127 cases. J Dermatol Treat 2009: 20: 100-108.
4. Dallocchio A, Canioni D, Ruemmele F, et al. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. Rheumatology 2010: 49 (9): 1694-1698.
5. Delaporte E,. Psoriasis and inflammatory bowel disease. Ann Dermatol Venereol 2012: 139 (Suppl. 2): S 46-S 52.
6. Fouache D, Goëb V, Massy-Guillemant N, et al. Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study. Rheumatology 2009: 48 (7): 761-764.
7. Wiegering V, Morbach H, Dick A, Girschick HJ,. Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature. Rheumatol Int 2010: 30 (6): 801-804.
8. Song IH, Appel H, Haibel H, et al. New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept. J Rheumatol 2008: 35 (3): 532-536.
9. Ahmad K, Rogers S,. Development of Crohn disease in a patient on etanercept for psoriasis. Br J Dermatol 2007: 157 (2): 396.
10. Tichy M Jr, Tichy M, Kopova R, Sternbersky J, Ditrichova D,. Psoriasis and psoriatic arthritis induced in a patient treated with infliximab for Crohn's disease. J Dermatol Treat 2012: 23 (3): 208-211.
11. Ellinghaus D, Ellinghaus E, Nair RP, et al. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am J Hum Genet 2012: 90 (4): 636-647.
12. Christophers E,. Comorbidities in psoriasis. J Eur Acad Dermatol Venereol 2006: 20: 52-55.
13. Gisondi P, Del Giglio M, Cozzi A, Girolomoni G,. Psoriasis, the liver, and the gastrointestinal tract. Dermatol Ther 2010: 23 (2): 155-159.
14. Oikonomou KA, Kapsoritakis AN, Tsiopoulos FD, Tsikouras AN, Potamianos S,. Emergence of Crohn's disease in juvenile idiopathic arthritis during treatment with etanercept: a causal link or a mere coincidence? J Gastrointestin Liver Dis 2010: 19 (3): 342.
15. Tichý M, Zapletalova J,. Experience with the systemic treatment of severe forms of psoriasis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012: 156 (1): 29-40.